content

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the fourth quarter and record-high earnings for the fiscal...

Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical

Fermenta Biotech Limited  announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy’s Laboratories...

Genezen appoints Senior Director of Business Development to support rapid growth

Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing...

19th Edition of BioAsia to focus on Future Readiness of the Life-Sciences Industry; 2-Day event to kick-start on February 24th

19th edition of the Asia’s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Government of Telangana will be held during...

Vetter’s Peter Soelkner featured on the “Molecule to Market” podcast

Peter Soelkner featured on the “Molecule to Market” podcast Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of...

Indian Pharmaceutical Industry Now And In The Days To Come

It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater...

Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina

Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read